Bragg Financial Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-824
Closed -$221K 257
2016
Q1
$221K Buy
824
+8
+1% +$2.29K 0.04% 241
2015
Q4
$255K Sell
816
-21
-3% -$6.25K 0.05% 221
2015
Q3
$228K Sell
837
-209
-20% -$64.2K 0.05% 216
2015
Q2
$317K Buy
1,046
+230
+28% +$68.6K 0.07% 207
2015
Q1
$243K Sell
816
-75
-8% -$21.4K 0.06% 219
2014
Q4
$229K Hold
891
0.06% 216
2014
Q3
$215K Buy
+891
New +$199K 0.05% 217
2014
Q1
Sell
-1,200
Closed -$202K 233
2013
Q4
$202K Buy
+1,200
New +$188K 0.05% 232

Other funds holding AGN

Bragg Financial Advisors's AGN Position: Q2 2016 in Review

Bragg Financial Advisors sold out of Allergan plc (AGN) in Q2 2016, closing a stake of 824 shares — an estimated $221K sold.

Bragg Financial Advisors first reported a position in AGN in Q4 2013 and held it in 8 quarters. The position peaked at $317K in Q2 2015. 1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

  • Bragg Financial Advisors reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
  • Bragg Financial Advisors sold 824 Allergan plc shares in Q2 2016, an estimated $221K.
  • Bragg Financial Advisors first reported a position in Allergan plc in Q4 2013 and held it in 8 quarters.
  • Bragg Financial Advisors's Allergan plc position peaked at $317K in Q2 2015.
  • 1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on Bragg Financial Advisors's 13F filing for Q2 2016, filed 15 Aug 2016.